TSC2 and tuberous sclerosis: Altogether, among the 116 unrelated individuals clinically diagnosed with TSC, 18 had pathogenic alterations in the TSC1 gene and 88 in TSC2, yielding a mutation detection rate of 91.4% (106/116; Table 1, Table 2 and Table 4).